Get started
Author

Diego Garcı́a-Borreguero

Observed names: D GARCIABORREGUERO, D Garcia-Borreguero, D García-Borreguero, D. Garcia-Borreguero, D. Garcia‐Borreguero, D. García-Borreguero, DIEGO GARCIA‐BORREGUERO, Diego GarcÍa-Borreguero, Diego Garcia Borreguero, Diego Garcia-Borreguero, Diego Garcia-Borreguero, MD, Diego Garcia‐Borreguero, Diego García-Borreguero, Diego García Borreguero, Diego García-Borreguero, Diego García‐Borreguero, Garcia-Borreguero, Diego, García-Borreguero, Diego
Observed institutions: Universidad Complutense de Madrid, Leiden University, National Institutes of Health, Max Planck Society, University Hospital Bonn, Leiden University Medical Center, Laboratoire Interdisciplinaire des Énergies de Demain, Instituto de Investigaciones del Sueño, Hospital Universitario Fundación Jiménez Díaz, Pfizer (Spain), Klinikum Bremerhaven-Reinkenheide, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Max Planck Institute of Psychiatry, National Institute of Mental Health, Centre d'études sociologiques et politiques Raymond-Aron, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Spanish Sleep Society, Universidad Autónoma de Madrid
ORCID: 0000-0003-1083-9654
Observed ORCID: 0000-0003-1083-9654
OpenAlex ID: A5040158309
European guideline for the diagnosis and treatment of insomnia
2017 · Dieter Riemann, Chiara Baglioni, et al. · Journal of Sleep Research · 2,051
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 · Richard P. Allen, Daniel L. Picchietti, et al. · Sleep Medicine · 1,616
PDF
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
2023 · Dieter Riemann, Colin A. Espie, et al. · Journal of Sleep Research · 830
PDF
The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG)
2006 · M ZUCCONI, R FERRI, et al. · Sleep Medicine · 455
Treatment of restless legs syndrome with gabapentin
2002 · D. Garcia-Borreguero, O. Larrosa, et al. · Neurology · 406
Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report
2017 · Richard P. Allen, Daniel L. Picchietti, et al. · Sleep Medicine · 353
PDF
Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation
2016 · Diego Garcia-Borreguero, Michael H. Silber, et al. · Sleep Medicine · 345
PDF
Altered Brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis–Ekbom Disease)
2014 · Christopher J. Earley, James Connor, et al. · Sleep Medicine · 337
The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group
2013 · Diego Garcia-Borreguero, Ralf Kohnen, et al. · Sleep Medicine · 291
PDF
Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine – International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute
2007 · Diego García-Borreguero, Richard P. Allen, et al. · Sleep Medicine · 287
Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
2004 · C Trenkwalder, D Garcia-Borreguero, et al. · PubMed · 283
Restless legs syndrome
2021 · Mauro Manconi, Diego Garcia-Borreguero, et al. · Nature Reviews Disease Primers · 280
Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome
2014 · Richard P. Allen, Crystal Chen, et al. · New England Journal of Medicine · 243
Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
2013 · Claudia Trenkwalder, Heike Beneš, et al. · The Lancet Neurology · 231
World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)
2016 · R. Ferri, S. Fulda, et al. · Sleep Medicine · 219
Epidemiology of restless legs syndrome: The current status
2006 · Diego Garcia-Borreguero, Renata Egatz, et al. · Sleep Medicine Reviews · 211
Low-Dose Hydrocortisone for Treatment of Chronic Fatigue Syndrome
1998 · Robin McKenzie, Ann O'Fallon, et al. · JAMA · 205
Parkinson's disease and sleep
2003 · Diego Garcia-Borreguero, Oscar Larrosa, et al. · Sleep Medicine Reviews · 204
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
2008 · Claudia Trenkwalder, Heike Beneš, et al. · The Lancet Neurology · 202
New Insights into the Neurobiology of Restless Legs Syndrome
2018 · Sergi Ferré, Diego García-Borreguero, et al. · The Neuroscientist · 158
Willis-Ekbom Disease Foundation Revised Consensus Statement on the Management of Restless Legs Syndrome
2013 · Michael H. Silber, Philip M. Becker, et al. · Mayo Clinic Proceedings · 154
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II
1995 · Claas-H. Lammers, Diego Garcia-Borreguero, et al. · Biological Psychiatry · 153
European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
2012 · Diego Garcia‐Borreguero, Luigi Ferini‐Strambi, et al. · European Journal of Neurology · 152
PDF
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
2011 · Wolfgang Oertel, Claudia Trenkwalder, et al. · The Lancet Neurology · 146
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep
2006 · L. Vignatelli, M. Billiard, et al. · European Journal of Neurology · 144
Works count: 242
Citation count: 14,910
H-index: 57
I10-index: 129
Year
Topic
Type